Related Experiment Video

Updated: May 13, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Recommendations for thromboprophylaxis in the 2012 focused update of the ESC guidelines on atrial fibrillation: a

G Y H Lip1

  • 1University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK. g.y.h.lip@bham.ac.uk

Journal of Thrombosis and Haemostasis : JTH
|March 5, 2013
PubMed

Insights

The 2012 European Society of Cardiology guidelines for atrial fibrillation management emphasize identifying low-risk patients for stroke prevention. Patients with stroke risk factors should receive oral anticoagulation therapy.

Area of Science:

  • Cardiology
  • Stroke Prevention
  • Atrial Fibrillation Management

Background:

  • The 2012 European Society of Cardiology (ESC) guidelines provide focused updates on atrial fibrillation (AF) management.
  • These guidelines advocate a shift in clinical practice for stroke prevention in AF patients.
  • Advances in risk assessment and novel therapies have emerged since the 2010 guidelines.

Purpose of the Study:

  • To provide a commentary on the 2012 ESC focused update recommendations for stroke prevention in AF.
  • To evaluate the evidence supporting these recommendations.
  • To discuss the practical implications of the updated guidelines.

Main Methods:

  • Review and commentary on the 2012 ESC guidelines for AF.
  • Analysis of the evidence base for stroke prevention strategies in AF.
  • Discussion of novel oral anticoagulants (NOACs) and left atrial appendage occlusion (LAAO) devices.

Main Results:

  • The guidelines recommend prioritizing the identification of 'truly low risk' patients who may not require antithrombotic therapy.
  • Oral anticoagulation therapy (warfarin or NOACs) is recommended for AF patients with at least one stroke risk factor.
  • Guidance is provided on stroke and bleeding risk assessment, NOACs, and LAAO devices.

Conclusions:

  • The 2012 ESC guidelines promote a risk-stratified approach to stroke prevention in AF.
  • Effective stroke prevention strategies, including oral anticoagulation, are crucial for AF patients with risk factors.
  • The guidelines incorporate recent advancements in risk assessment and therapeutic options for AF management.

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...